Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Showing results for

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.

COVID-19 treatments in care homes

Methods for the development and validation of computable phenotypes based on biobanks and linked real world data

Deadline - Friday 15 May 2026

Measuring the mathematical similarity and distance between real-world databases and their transformation into Common Data Models: an OMOP case study to strengthen data quality in observational research

Artificial Intelligence for musculoskeletal global health

People Powered Research – Investigating ethical and operational hurdles in public-research engagement

Assessing the use of treatments for blood cancers using real world data

Fibrosis across musculoskeletal tissues: Comparison of resolving and persistent fibrotic niches

Pro-resolving therapies: A new therapeutic paradigm targeting inflammation in equine tendon injury

Advanced Analysis of 15-Year Outcomes in the Arterial Revascularization Trial: Implications for CABG Strategies

Modelling recovery after common hand surgery procedures

Emulating and extending randomised controlled trials using routinely-collected data from Europe

Large language models for phenotyping in Real World Evidence distributed analytics: bridging expert knowledge and artificial intelligence

Improving the quality of real world evidence by measuring and minimising outcome misclassification using the OMOP common data model and large multinational health data

Osteogenic-angiogenic coupling in fracture repair - Why do some patients fail to heal?

Investigating pro-inflammatory vs pro-remission mechanisms across immune disorders: integrating single-cell/spatial multiomics & ML/AI approaches for patient-level translational insights

Investigating pro-inflammatory vs pro-remission mechanisms across immune disorders: integrating single-cell/spatial multiomics & ML/AI approaches for patient-level translational insights

Multi-dimensional analysis of the immunological synapse in the context of immunotherapy

Virtual Immune Cells – Combing Mechanism, Genomics & AI to Predict T cell responses

Multi-dimensional analysis of the immunological synapse in the context of immunotherapy

Multi-dimensional analysis of the immunological synapse in the context of immunotherapy

Integrated Ultrasound-Enhanced Biophotonic Platform for High-Throughput Studies of Cancer–Immune Cell Mechanobiology

Load More

1
2
3
4
5